Related Experiment Videos

Unique issues in the development of "targeted" antineoplastic pharmaceutical agents

Current Oncology Reports

|June 11, 2005

Summary

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

The IMMUNO-BIOMAP trial in NSCLC: An adaptive multimodal framework for biomarker-guided care.

Cell reports. Medicine·2026

Use of ALK Inhibitors in Patients With Nonlung Malignancies Bearing ALK Alteration Prolongs Treatment Duration.

JCO precision oncology·2026

What proportion of patients with stage 3 ovarian cancer are potentially cured following intraperitoneal chemotherapy? Analysis of the long term (≥10 years) survivors in NRG/GOG randomized clinical trials of intraperitoneal and intravenous chemotherapy in stage III ovarian cancer.

Gynecologic oncology·2022

Phase II study of intraperitoneal submicron particle paclitaxel (SPP) plus IV carboplatin and paclitaxel in patients with epithelial ovarian cancersurgery.

Gynecologic oncology reports·2020

The Evolving Arena of Ovarian Cancer Maintenance Therapy.

Oncology·2019

Pharmaceutical Management of Ovarian Cancer: Current Status.

Drugs·2019

See all related articles